Aktiesnakken — Oktober 2010
-
lidt genmab frisk fra fad http://www.reuters.com/article/idUSLDE69P0BU20101026
-
the share price does not take into account the company's pipeline or its technology platforms, which should give a market capitalisation "ma
-
ny time higher"!!!!!
-
så kan det vist ikke siges klarere
-
ud fra devisen 1, 2-
mange? -
vestas 201
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind